Regulating medicines in the post-Brexit era

摘要

A worst-case scenario says that relocating the European Medicines Agency could permanently damage the medicines regulatory system, leading to a public health crisis in both Europe and the UK. On 20 November, the General Affairs Council of the European Union will officially announce the new location of the European Medicines Agency (EMA).